Zodryl DEC 80 is a Oral Suspension in the Human Otc Drug category. It is labeled and distributed by Codadose, Inc.. The primary component is Pseudoephedrine; Codeine Phosphate; Guaifenesin.
| Product ID | 43378-126_5e3f17d1-bcb6-4d05-bdd7-59012af8cf4b |
| NDC | 43378-126 |
| Product Type | Human Otc Drug |
| Proprietary Name | Zodryl DEC 80 |
| Generic Name | Codeine Phosphate, Guaifenesin And Pseudoephedrine Hydrochloride |
| Dosage Form | Suspension |
| Route of Administration | ORAL |
| Marketing Start Date | 2009-08-24 |
| Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Labeler Name | CodaDose, Inc. |
| Substance Name | PSEUDOEPHEDRINE; CODEINE PHOSPHATE; GUAIFENESIN |
| Active Ingredient Strength | 30 mg/10mL; mg/10mL; mg/10mL |
| DEA Schedule | CV |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
| Marketing Start Date | 2009-08-24 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | OTC monograph final |
| Application Number | part341 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2009-08-24 |
| Inactivation Date | 2019-10-21 |
| Ingredient | Strength |
|---|---|
| PSEUDOEPHEDRINE | 30 mg/10mL |
| SPL SET ID: | 20019e0e-7da5-4126-8595-06ec42ee8322 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 43378-126 | Zodryl DEC 80 | codeine phosphate, guaifenesin and pseudoephedrine hydrochloride |
| 43378-120 | Zodryl DEC 25 | codeine phosphate, guaifenesin and pseudoephedrine hydrochloride |
| 43378-121 | Zodryl DEC 30 | codeine phosphate, guaifenesin and pseudoephedrine hydrochloride |
| 43378-123 | Zodryl DEC 40 | codeine phosphate, guaifenesin and pseudoephedrine hydrochloride |
| 43378-124 | Zodryl DEC 50 | codeine phosphate, guaifenesin and pseudoephedrine hydrochloride |
| 43378-125 | Zodryl DEC 60 | codeine phosphate, guaifenesin and pseudoephedrine hydrochloride |